title: Chronic hepatitis.
authors.affiliation: Hepatobiliary Program, Seattle Children's Hospital and Regional Medical Center, Seattle, WA 98105, USA. karen.murray@seattlechildrens.org
authors.forename: Karen F
authors.initials: KF
authors.lastname: Murray
authors.forename: Uzma
authors.initials: U
authors.lastname: Shah
authors.forename: Neelam
authors.initials: N
authors.lastname: Mohan
authors.forename: Solange
authors.initials: S
authors.lastname: Heller
authors.forename: Regino P
authors.initials: RP
authors.lastname: González-Peralta
authors.forename: Deirdre
authors.initials: D
authors.lastname: Kelly
authors.forename: Mei-Hwei
authors.initials: MH
authors.lastname: Chang
authors.forename: Giorgina
authors.initials: G
authors.lastname: Mieli-Vergani
authors.forename: Paloma
authors.initials: P
authors.lastname: Jara
authors.forename: Tomoo
authors.initials: T
authors.lastname: Fujisawa
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D003937:Diagnosis, Differential; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000401:mortality; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000401:mortality; D019693:Hepatitis, Autoimmune / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D012307:Risk Factors
chemical_list: D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents